Head and Neck Carcinomas Across the Age Spectrum: Epidemiology, Therapy, and Late Effects

Seminars in Radiation Oncology

Volumn 20, Issue 1, 2010, Pages 52-57

  Marcus, Karen J ^a   Tishler, Roy B ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; METHOTREXATE; VINBLASTINE;

AGE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG DOSE SEQUENCE; ENDOCRINE DISEASE; ENDOSCOPY; EPSTEIN BARR VIRUS; HUMAN; MUCOSA INFLAMMATION; MUSCULOSKELETAL DISEASE; NASOPHARYNX CARCINOMA; NECK DISSECTION; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OTOTOXICITY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SEROUS OTITIS MEDIA; SKIN IRRITATION; THERAPY EFFECT; VIRUS CARCINOGENESIS; XEROSTOMIA;

ADULT; AGE DISTRIBUTION; CARCINOMA, SQUAMOUS CELL; CHILD; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; NEUROBLASTOMA; RADIOTHERAPY; RHABDOMYOSARCOMA;

EID: 70549101370     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2009.09.004     Document Type: Review

References (31)

1. Deutsch M., Mercado Jr. R., and Parsons J.A. Cancer of the nasopharynx in children. Cancer 41 (1978) 1128-1133
2. Ingersoll L., Woo S.Y., and Donaldson S. Nasopharyngeal carcinoma in the young: A combined M.D. Anderson and Stanford experience. Int J Radiat Oncol Biol Phys 19 (1990) 881-887
3. Mertens R., Granzen B., and Lassay L. Nasopharyngeal carcinoma in childhood and adolescence: Concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft fur Padiatrische Onkologie und Hamatologie. Cancer 80 (1997) 951-959
4. Bray F., Haugen M., and Moger T.A. Age-incidence curves of nasopharyngeal carcinoma worldwide: Bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev 17 (2008) 2356-2365
5. Ayan I., and Altun M. Nasopharyngeal carcinoma in children: Retrospective review of 50 patients. Int J Radiat Oncol Biol Phys 35 (1996) 485-492
6. Levine P.H., Connelly R.R., and Easton J.M. Demographic patterns for nasopharyngeal carcinoma in the United States. Int J Cancer 26 (1980) 741-748
7. Har-Kedar I., Chaitchik S., and Hercberg A. Nasopharyngeal carcinoma at the Tel-Hashomer Government Hospital, Israel. A 20 year survey (1951-1970). Clin Radiol 25 (1974) 403-407
8. Hu D.E., Ling X.S., and Hu J. The effects of radiotherapy on the immune system of patients with nasopharyngeal carcinoma. Br J Radiol 61 (1988) 305-308
9. Vasef M.A., Ferlito A., and Weiss L.M. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus. Ann Otol Rhinol Laryngol 106 (1997) 348-356
10. Cohen J.I. Epstein-Barr virus infection. N Engl J Med 343 (2000) 481-492
11. Preciado M.V., Chabay P.A., and De Matteo E.N. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: Its correlation with p53 and bcl-2 expression. Med Pediatr Oncol 38 (2002) 345-348
12. Vokes E.E., Liebowitz D.N., and Weichselbaum R.R. Nasopharyngeal carcinoma. Lancet 350 (1997) 1087-1091
13. Claudio P.P., Howard C.M., and Fu Y. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma. Cancer Res 60 (2000) 8-12
14. Wang C.C. Radiation Therapy for Head and Neck Neoplasms. (ed 3) (1997), Wiley-Liss, New York, NY
15. Stambuk H.E., Patel S.G., and Mosier K.M. Nasopharyngeal carcinoma: Recognizing the radiographic features in children. Am J Neuroradiol 26 (2005) 1575-1579
16. Fleming I., Cooper J., and Henson D. AJCC Cancer Staging Manual. (ed 5) (1997), Lippincott-Raven, Philadelphia, PA
17. Wolden S.L., Steinherz P.G., and Kraus D.H. Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. Int J Radiat Oncol Biol Phys 46 (2000) 859-864
18. Ayan I., Kaytan E., and Ayan N. Childhood nasopharyngeal carcinoma: From biology to treatment. Lancet Oncol 4 (2003) 13-21
19. Zubizarreta P.A., D'Antonio G., and Raslawski E. Nasopharyngeal carcinoma in childhood and adolescence: A single-institution experience with combined therapy. Cancer 89 (2000) 690-695
20. Wolden S.L., Chen W.C., and Pfister D.G. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64 (2006) 57-62
21. Laskar S., Bahl G., and Muckaden M. Nasopharyngeal carcinoma in children: Comparison of conventional and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 72 (2008) 728-736
22. Al-Sarraf M., LeBlanc M., and Giri P.G. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317
23. Ma J., Mai H.Q., and Hong M.H. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 19 (2001) 1350-1357
24. Chan A.T., Teo P.M., and Ngan R.K. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial. J Clin Oncol 20 (2002) 2038-2044
25. Chan A.T., Leung S.F., and Ngan R.K. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97 (2005) 536-539
26. Baujat B., Audry H., and Bourhis J. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64 (2006) 47-56
27. Hui E.P., Ma B.B., and Leung S.F. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol 27 (2009) 242-249
28. Jenkin R.D., Anderson J.R., and Jereb B. Nasopharyngeal carcinoma-a retrospective review of patients less than thirty years of age: A report of Children's Cancer Study Group. Cancer 47 (1981) 360-366
29. Varan A., Ozyar E., and Corapcioglu F. Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation cisplatin and docetaxel chemotherapy. Int J Radiat Oncol Biol Phys 73 (2009) 1116-1120
30. Lombardi F., Gasparini M., and Gianni C. Nasopharyngeal carcinoma in childhood. Med Pediatr Oncol 10 (1982) 243-250
31. Uzel O., Yoruk S.O., and Sahinler I. Nasopharyngeal carcinoma in childhood: Long-term results of 32 patients. Radiother Oncol 58 (2001) 137-141